article · BMC Endocrine Disorders

Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in Tanzania: prevalence and predictors

2026Open accessCatholic University of Health and Allied Sciences

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Liver Disease Diagnosis and Treatment
Diabetes, Cardiovascular Risks, and Lipoproteins
Drug-Induced Hepatotoxicity and Protection

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12902-026-02179-0

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.